DESCRIPTION:

This talk will review current FDA approved indications for CAR T-Cell therapy in multiple myeloma, toxicities of CAR T-Cell therapy, bridging therapy prior to CAR T-Cell therapy, and future approaches for the use of CAR-T Cell therapy in multiple myeloma.

 

LEARNING OBJECTIVES

  • Review FDA approved indications for CAR T-Cell therapy in multiple myeloma
  • Review approaches to bridging therapy in CAR T-Cell Therapy in multiple myeloma
  • Discuss future approaches for the use of CAR-T Cell therapy in multiple myeloma

 

Session date: 
11/10/2025 - 12:00pm to 1:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Benjamin Massat, D.O.